Insider · CIK 0001860326
Gabriela Gruia
Files at MTEM (Molecular Templates, Inc.), APRE (Aprea Therapeutics, Inc.), TCRX (TScan Therapeutics, Inc.). First filing -, latest -.
In brief
Gabriela Gruia files SEC Form 4 as director at MTEM (Molecular Templates, Inc.), and also at APRE (Aprea Therapeutics, Inc.), TCRX (TScan Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gabriela Gruia has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | APRE Aprea Therapeutics, Inc. | AGrant or award Common Stock | +3,135 | $0.00 | $0 | 4,180 | Jun 17, 2026 |
| Jun 16, 2026 | APRE Aprea Therapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +12,555 | $0.00 | $0 | 12,555 | Jun 17, 2026 |
| May 20, 2026 | TCRX TScan Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +67,000 | $0.00 | $0 | 67,000 | May 22, 2026 |
| Jun 30, 2025 | TCRX TScan Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +67,000 | $0.00 | $0 | 67,000 | Jul 2, 2025 |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | AGrant or award Common Stock | +1,045 | $0.00 | $0 | 1,045 | Jun 9, 2025 |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +4,185 | $0.00 | $0 | 4,185 | Jun 9, 2025 |
| Jun 12, 2024 | TCRX TScan Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +47,500 | $0.00 | $0 | 47,500 | Jun 14, 2024 |
| Oct 27, 2023 | MTEM Molecular Templates, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,000 | $0.00 | $0 | 1,000 | Oct 31, 2023 |
Questions about Gabriela Gruia
Answered from the filings on this page, as of the latest one.
Is Gabriela Gruia buying or selling?
Gabriela Gruia has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gabriela Gruia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gabriela Gruia has 0.
Where does Gabriela Gruia file Form 4?
Gabriela Gruia has filed Form 4 at MTEM (Molecular Templates, Inc.); APRE (Aprea Therapeutics, Inc.); TCRX (TScan Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.